Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04452383
Other study ID # Sedation in DISE
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date July 23, 2020
Est. completion date December 30, 2021

Study information

Verified date December 2021
Source Zagazig University
Contact Heba M EL-Asser, MD
Phone 01062393152
Email aseelaswad1@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigator compared the sedative effects of propofol alone and ketamine added to propofol in drug induced sleep endoscopy


Description:

Propofol and ketamineare commonly used intravenous anesthetic drug used for procedural sedation. The investigator compared the effect of propofol and propofol ketamine in patients undergoing drug induced sleep endoscopy.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date December 30, 2021
Est. primary completion date December 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria - Age > 18 years old. - American society of anesthesiologists (ASA) physical status I or II. I / II Exclusion Criteria: - patient refusal - American society of anesthesiologists (ASA) physical status > III - known or suspected allergy to the studied drugs or its components, allergy to eggs or soy beans - morbid obesity - patients with moderate to severe chronic obstructive pulmonary disease or uncontrolled asthma, congestive e heart failure ,seizures ,or cerebrovascular disease - pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ketamine + propofol
effect of adding ketamine to propofol for patients undergoing DISE surgery
propofol
effect of IV propofol alone for patients undergoing DISE surgery

Locations

Country Name City State
Egypt zagazig University Zagazig Sarkia

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Cho JS, Soh S, Kim EJ, Cho HJ, Shin S, Kim HJ, Koo BN. Comparison of three sedation regimens for drug-induced sleep endoscopy. Sleep Breath. 2015 May;19(2):711-7. doi: 10.1007/s11325-015-1127-9. Epub 2015 Feb 3. — View Citation

De Vito A, Agnoletti V, Berrettini S, Piraccini E, Criscuolo A, Corso R, Campanini A, Gambale G, Vicini C. Drug-induced sleep endoscopy: conventional versus target controlled infusion techniques--a randomized controlled study. Eur Arch Otorhinolaryngol. 2011 Mar;268(3):457-62. doi: 10.1007/s00405-010-1376-y. Epub 2010 Sep 2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with successful completion of the procedure (with diagnosis of site and degree of obstruction) Number of patients with successful completion of the procedure (with diagnosis of site and degree of obstruction) the duration of the procedure under sedation is usually about 20 minutes to complete the procedure
Secondary time until su?cient sedation to start endoscopy time to start endoscopy is de?ned as the duration between start of the studied drugs until MOAA/S Modified observer assessment scale of alertness sedaion score 1 was obtained. It is about 5-10 minutes from start of studied drug till patient is ready to start endoscopy
Secondary The total propofol and ketamine dose(mg)/patient needed/patient was calculated The total propofol and ketamine(mg) /patient dose needed/patient was calculated the procedure
Secondary any airway intervention and occurrence of laryngospasm after start of the DISE procedure until its completion with diagnosis of site and degree of obstruction Once the DISE began, the airway interventions were important as outcomes, because these interrupted the clinical study of the DISE. Furthermore, laryngospasm was de?ned by the requirement for positive pressure ventilation of >20 cmH2O or administration of succinylcholine or propofol or any . the procedure
Secondary Adverse events (hypotension, bradycardia, arrhythmia, laryngospasm, cough, gag re?ex, apnea or aspiration) were recorded during the procedure Bradycardia was diagnosed if heart rate dropped below 60beats/min and atropine 0.01mg/kg was given if HR decreased below 50beats/min. Hypotension was diagnosed if mean arterial blood pressure (MAP) decreased by more than 30% from baseline or below 60mmHg the procedure
Secondary Time till Recovery Time between stop of the study drugs until Modified observer's assessment of alertness sedation MOAA/S score of 4 was calculated and patient is shifted to recovery room( MOAA/S score btween 0-6 where 1 patient is ready for endoscopic airway evaluation and 1 patient is ready for discharge to recovery room ) Time till (MOAA/S) score 4 was calculated . an average of 5 minutes between stop of drugs until Modified observer's assessment of alertness sedation MOAA/S became 4
Secondary patients and surgeon satisfaction Both patients' and surgeon satisfaction were recorded using a 7-point Likert-like verbal rating scales for patients and surgeon satisfaction where 7 is extremely satisfied and 1 is extremely dissatisfied about 30 minutes after complete recovery both patients' and surgeon satisfaction were recorded using a 7-point Likert-like verbal rating scales for patients and surgeon satisfaction where 7 is extremely satisfied and 1 is extremely dissatisfied
Secondary Time to Aldrete's recovery scores became 10 (maximum) (patient is ready to discharge) was recored post procedure in the recovery room Time to Aldrete's recovery scores became 10 (maximum)(patient is ready to discharge) was recorded post procedure in the recovery room Average 15-30 minutes post procedure to have Aldrete's recovery scores 10 (maximum) (patient is ready to discharge) in the recovery room
See also
  Status Clinical Trial Phase
Recruiting NCT05477719 - Effect of Compression Stockings on the Number of Apneas/Hypopneas Per Hour of Sleep in Patients With Syndrome Obstructive Sleep Apnea/Hypopnea as Compared to no Treatment N/A
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A
Terminated NCT02735694 - Cycloserine in the Treatment of Sleep Apnea Phase 1
Active, not recruiting NCT02470182 - Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
Completed NCT02088723 - Testing the Elevation as Sleep Apnea Treatment N/A
Completed NCT01457014 - Sleep Disordered Breathing and Chronic Pain N/A
Completed NCT00860743 - Respiratory and Autonomic Plasticity Following Intermittent Hypoxia Early Phase 1
Completed NCT00976417 - Mechanisms of Action of Adaptive Servoventilation N/A
Active, not recruiting NCT00371293 - The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease N/A
Completed NCT00607893 - Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea N/A
Completed NCT00070681 - Outcomes of Sleep Disorders in Older Men Phase 3
Completed NCT00083798 - Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland N/A
Completed NCT00089752 - Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea N/A
Completed NCT00046670 - Sleep Disordered Breathing, APOE, and Lipid Metabolism N/A
Completed NCT00051363 - Apnea Positive Pressure Long-Term Efficacy Study Phase 3
Completed NCT00031239 - Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD N/A
Completed NCT00006323 - Neurobehavioral Consequences of Sleep Apnea in Children N/A
Terminated NCT00006321 - Neurocognitive Function in Snoring Children N/A
Completed NCT00005511 - SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea N/A
Completed NCT00005275 - Sleep Heart Health Study (SHHS) Data Coordinating Center N/A